United States · FDA National Drug Code directory

Scopolamine Transdermal System

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
45802-580_d334a21d-7546-477f-a66a-f95b2cf523ce
Product NDC
45802-580
Form
PATCH, EXTENDED RELEASE
Composition / generic term
scopolamine transdermal system
Labeler
Padagis Israel Pharmaceuticals Ltd
Marketing category
ANDA
Marketing start / end (source format)
20170613 / 20280630

Source-listed ingredients

  • SCOPOLAMINE — 1 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 10 POUCH in 1 CARTON (45802-580-46) / 1 PATCH, EXTENDED RELEASE in 1 POUCH · 45802-580-46
  • 24 POUCH in 1 CARTON (45802-580-62) / 1 PATCH, EXTENDED RELEASE in 1 POUCH · 45802-580-62
  • 4 POUCH in 1 CARTON (45802-580-84) / 1 PATCH, EXTENDED RELEASE in 1 POUCH · 45802-580-84

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →